Retrouvez les publications scientifiques majeures relatives à l’hypertension pulmonaire auxquelles les membres des centres de référence et de compétence PulmoTension ont contribué.
Publications
Rechercher une publication :
-
09/2024
Thirty years of surgical management of pediatric pulmonary hypertension: Mid-term outcomes following reverse Potts shunt and transplantation (nouvel onglet)
J Thorac Cardiovasc Surg. 2024 Sep;168(3):943-954. doi: 10.1016/j.jtcvs.2023.11.045. Epub 2023 Dec 3. PMID: 38052251.
-
08/2024
Comparative Effectiveness of Sotatercept and Approved Add-On Pulmonary Arterial Hypertension Therapies: A Systematic Review and Network Meta-Analysis (nouvel onglet)
Ann Am Thorac Soc. 2024 Aug;21(8):1194-1203. doi: 10.1513/AnnalsATS.202311-942OC. PMID: 38820258.
-
08/2024
Development and validation of a code-based algorithm using in-hospital medical records to identify patients with pulmonary arterial hypertension in a French healthcare database (nouvel onglet)
ERJ Open Res. 2024 Aug 12;10(4):00109-2024. doi: 10.1183/23120541.00109-2024. PMID: 39135662; PMCID: PMC11317892
-
07/2024
Pulmonary Hypertension Induced by Right Pulmonary Artery Occlusion: Hemodynamic Consequences of Bmpr2 Mutation (nouvel onglet)
J Am Heart Assoc. 2024 Jul 16;13(14):e034621. doi: 10.1161/JAHA.124.034621. Epub 2024 Jul 9. PMID: 38979789; PMCID: PMC11292755
-
07/2024
Unmet need in pulmonary hypertension-associated interstitial lung disease (PH-ILD): a clinician survey of real-world management of PH-ILD in Europe (nouvel onglet)
ERJ Open Res. 2024 Jul 8;10(4):00039-2024. doi: 10.1183/23120541.00039-2024. PMID: 38978553; PMCID: PMC11228598
-
07/2024
Role of KCNK3 Dysfunction in Dasatinib-associated Pulmonary Arterial Hypertension and Endothelial Cell Dysfunction (nouvel onglet)
Am J Respir Cell Mol Biol. 2024 Jul;71(1):95-109. doi: 10.1165/rcmb.2023-0185OC. PMID: 38546978
-
07/2024
Medication adherence, related factors and outcomes among patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension: a systematic review (nouvel onglet)
Eur Respir Rev. 2024 Jul 3;33(173):240006. doi: 10.1183/16000617.0006-2024. PMID: 38960611; PMCID: PMC11220621
-
07/2024
Risk Assessment in Pulmonary Veno-Occlusive Disease: The First Step Towards Future Trials? (nouvel onglet)
Arch Bronconeumol. 2024 Jul;60(7):395-396. English, Spanish. doi: 10.1016/j.arbres.2024.04.011. Epub 2024 Apr 25. PMID: 38705810
-
06/2024
Characteristics and outcomes of patients developing pulmonary hypertension associated with proteasome inhibitors (nouvel onglet)
Eur Respir J. 2024 Jun 28;63(6):2302158. doi: 10.1183/13993003.02158-2023. PMID: 38697649
-
06/2024
Evidence and unresolved questions in pulmonary hypertension: Insights from the 5th French Pulmonary Hypertension Network Meeting (nouvel onglet)
Respir Med Res. 2024 Nov;86:101123. doi: 10.1016/j.resmer.2024.101123. Epub 2024 Jun 22. PMID: 38972109.